Shuibao Xu
- Infectious Diseases top 5%
- Antifungal resistance and susceptibility 4
- COVID-19 Clinical Research Studies 4
- SARS-CoV-2 and COVID-19 Research 3
- Neurology top 5%
- Modeling and Simulation top 5%
-
- Viral-associated cancers and disorders 4
-
- Fungal Infections and Studies 4
- Pneumocystis jirovecii pneumonia detection and treatment 3
- Cytomegalovirus and herpesvirus research 3
-
- HIV Research and Treatment 3
- Partner nations
- China
In The Last Decade
Shuibao Xu
15 papers receiving 725 citations
Hit Papers
Peers
Comparison fields: 5 of 101
- Infectious Diseases 534
- Neurology 246
- Modeling and Simulation 57
- Critical Care and Intensive Care Medicine 44
- Oncology 138
Countries citing papers authored by Shuibao Xu
This map shows the geographic impact of Shuibao Xu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shuibao Xu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shuibao Xu more than expected).
Fields of papers citing papers by Shuibao Xu
This network shows the impact of papers produced by Shuibao Xu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shuibao Xu. The network helps show where Shuibao Xu may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Shuibao Xu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2025 | 0 | |
| 3 | 2025 | 0 | |
| 4 | 2025 | 1 | |
| 5 | 2024 | 1 | |
| 6 | 2024 | 3 | |
| 7 | 2023 | 2 | |
| 8 | 2023 | 1 | |
| 9 | 2023 | 0 | |
| 10 | 2023 | 2 | |
| 11 | 2022 | 4 | |
| 12 | 2022 | 7 | |
| 13 | 2021 | 20 | |
| 14 | 2021 | 9 | |
| 15 | 2021 | 17 | |
| 16 | 2021 | 3 | |
| 17 | 2020 | 11 | |
| 18 | Clinical progression of patients with COVID-19 in Shanghai, Chinabreakdown → | 2020 | 582 |
| 19 | 2020 | 90 |
About Shuibao Xu
Shuibao Xu is a scholar working on Infectious Diseases, Virology and Biological Psychiatry, having authored 19 papers that have together received 753 indexed citations. Recurring topics across this work include Viral-associated cancers and disorders (4 papers), Antifungal resistance and susceptibility (4 papers), Fungal Infections and Studies (4 papers), COVID-19 Clinical Research Studies (4 papers), SARS-CoV-2 and COVID-19 Research (3 papers), HIV Research and Treatment (3 papers), Pneumocystis jirovecii pneumonia detection and treatment (3 papers) and Cytomegalovirus and herpesvirus research (3 papers). The work is most often cited by research in Infectious Diseases (534 citations), Neurology (246 citations) and Modeling and Simulation (57 citations). Shuibao Xu has collaborated with scholars based in China. Frequent co-authors include Jun Chen, Hongzhou Lu, Li Liu, Yun Ling, Qingnian Xu, Yinzhong Shen, Tangkai Qi, Yuyi Zhang, Tongyu Zhu and Zhiping Qian. Their work appears in journals such as Frontiers in Immunology, AIDS and Journal of Medical Microbiology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.